1-3 of 3
Elizabeth A. Chavez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma

Kit I. Tong, Sharon Yoon, Keren Isaev, Mehran Bakhtiari, Tracy Lackraj, Michael Y. He, Jesse Joynt, Anjali Silva, Maria C. Xu, Gilbert G. Privé, Housheng Hansen He, Rodger E. Tiedemann, Elizabeth A. Chavez, Lauren C. Chong, Merrill Boyle, David W. Scott, Christian Steidl, Robert Kridel
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (19): 5401–5414.
https://doi.org/10.1158/1078-0432.CCR-20-4027
Published: 01 October 2021
View article titled, Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma
Open the PDF for Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer

Céline M. Laumont, Maartje C.A. Wouters, Julian Smazynski, Nicole S. Gierc, Elizabeth A. Chavez, Lauren C. Chong, Shelby Thornton, Katy Milne, John R. Webb, Christian Steidl, Brad H. Nelson
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (14): 4089–4100.
https://doi.org/10.1158/1078-0432.CCR-20-4394
Published: 15 July 2021
View article titled, Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Open the PDF for Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association

Robert Kridel, Luc Xerri, Bénédicte Gelas-Dore, King Tan, Pierre Feugier, Ayesha Vawda, Danielle Canioni, Pedro Farinha, Sami Boussetta, Alden A. Moccia, Pauline Brice, Elizabeth A. Chavez, Alastair H. Kyle, David W. Scott, Ashley D. Sanders, Bettina Fabiani, Graham W. Slack, Andrew I. Minchinton, Corinne Haioun, Joseph M. Connors, Laurie H. Sehn, Christian Steidl, Randy D. Gascoyne, Gilles Salles
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (15): 3428–3435.
https://doi.org/10.1158/1078-0432.CCR-14-3253
Published: 02 August 2015
View article titled, The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association
Open the PDF for The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association in another window
Includes: Supplementary data